Status:
COMPLETED
Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling
Lead Sponsor:
Klinikum Bayreuth GmbH
Conditions:
Influenza
Eligibility:
All Genders
18+ years
Brief Summary
Multicapillary Ion mobility spectrometry of nasal air aspirates shall be investigated as screening tool for the detection of Influenza and SARS-CoV-2- infection.
Detailed Description
Bacterial infections can be distinguished by analysis of the volatile organic compounds found in breath. In patients with suspected Influenza infection, nasal air samples will be taken and analyzed b...
Eligibility Criteria
Inclusion
- suspected Influenza infection
Exclusion
- later than 48h after admission and detection of Influenza infection
- later than 32 days after admission and detection of SARS-CoV-2- infection
- no written consent
Key Trial Info
Start Date :
February 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04282135
Start Date
February 15 2020
End Date
June 30 2020
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Bayreuth
Bayreuth, Germany, 95445